A significant effect of OT-administration on the delayed excitatory-to-inhibitory developmental GABA shift (at P7), delays that are observed in various neurodevelopmental disorders, underlies the therapeutic use of neonatal oxytocin in these disorders. The gene discussed is OXT; the disease is neurodevelopmental disorder.